Your browser doesn't support javascript.
loading
Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu, Fangmeng; Yu, Liuwen; Zeng, Bangwei; Chen, Minyan; Guo, Wenhui; Chen, Lili; Lin, Yuxiang; Hou, Jialin; Li, Jing; Li, Yan; Li, Shengmei; Chen, Xiaobin; Zhang, Wenzhe; Jin, Xuan; Cai, Weifeng; Zhang, Kun; Chen, Hanxi; Qiu, Yibin; Nie, Qian; Wang, Chuan; Jacobs, Lisa.
Afiliación
  • Fu F; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Yu L; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Zeng B; Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian, Fujian Province, China.
  • Chen M; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Guo W; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Chen L; Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian, Fujian Province, China.
  • Lin Y; Administration Department of Nosocomial Infection, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.
  • Hou J; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Li J; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Li Y; Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian, Fujian Province, China.
  • Li S; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Chen X; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Zhang W; Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian, Fujian Province, China.
  • Jin X; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Cai W; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Zhang K; Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian, Fujian Province, China.
  • Chen H; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Qiu Y; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Nie Q; Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian, Fujian Province, China.
  • Wang C; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
  • Jacobs L; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, Fujian Province, China.
JAMA Netw Open ; 5(2): e2145934, 2022 02 01.
Article en En | MEDLINE | ID: mdl-35166783
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Quimioterapia Adyuvante / Receptor ErbB-2 / Antineoplásicos Hormonales / Tiempo de Tratamiento Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: JAMA Netw Open Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Quimioterapia Adyuvante / Receptor ErbB-2 / Antineoplásicos Hormonales / Tiempo de Tratamiento Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: JAMA Netw Open Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos